BioMotiv and New York University join forces to form Orca Pharmaceuticals, a new autoimmune disease company

Orca Pharmaceuticals, a new biotechnology start-up focused on treating autoimmune diseases, has today announced its formation. Funding is from BioMotiv, a Cleveland, Ohio based therapeutics accelerator affiliated with The Harrington Project, and the New York University Innovation Venture Fund. The company, located in Oxford UK, is based on technology developed by inventors from New York University (NYU) in collaboration with the founders in the United Kingdom.

Click here for more